EyeGene,Inc
Develops gene/cell therapies & mRNA vaccines for age-related and ocular diseases.
185490 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 의왕시 양지편2로 13 2층, 의왕시
- Website:
- https://eyegene.co.kr/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
EyeGene, Inc. is a clinical-stage biotechnology company focused on the research and development of innovative biopharmaceuticals. The company is pioneering gene and cell therapies to create transformative treatments for various conditions, with a historical focus on age-related and ocular diseases. Leveraging advanced technologies such as mRNA platforms and immunology, EyeGene develops a pipeline of novel therapeutics and vaccines. The company aims to become a global biopharmaceutical leader by advancing treatment and prevention through data-driven research to address unmet medical needs.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for EyeGene,Inc and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all EyeGene,Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for EyeGene,Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
